Cargando…
Primary lung cancer in women after previous breast cancer
BACKGROUND: Breast cancer is the most common malignancy among women in the USA. Improved survival has resulted in increasing incidence of second primary malignancies, of which lung cancer is the most common. The United States Preventive Services Task Force (USPSTF) guidelines for lung-cancer screeni...
Autores principales: | , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8765335/ https://www.ncbi.nlm.nih.gov/pubmed/35040941 http://dx.doi.org/10.1093/bjsopen/zrab115 |
_version_ | 1784634315461623808 |
---|---|
author | Nobel, Tamar B Carr, Rebecca A Caso, Raul Livschitz, Jennifer Nussenzweig, Samuel Hsu, Meier Tan, Kay See Sihag, Smita Adusumilli, Prasad S Bott, Matthew J Downey, Robert J Huang, James Isbell, James M Park, Bernard J Rocco, Gaetano Rusch, Valerie W Jones, David R Molena, Daniela |
author_facet | Nobel, Tamar B Carr, Rebecca A Caso, Raul Livschitz, Jennifer Nussenzweig, Samuel Hsu, Meier Tan, Kay See Sihag, Smita Adusumilli, Prasad S Bott, Matthew J Downey, Robert J Huang, James Isbell, James M Park, Bernard J Rocco, Gaetano Rusch, Valerie W Jones, David R Molena, Daniela |
author_sort | Nobel, Tamar B |
collection | PubMed |
description | BACKGROUND: Breast cancer is the most common malignancy among women in the USA. Improved survival has resulted in increasing incidence of second primary malignancies, of which lung cancer is the most common. The United States Preventive Services Task Force (USPSTF) guidelines for lung-cancer screening do not include previous malignancy as a high-risk feature requiring evaluation. The aim of this study was to compare women undergoing resection for lung cancer with and without a history of breast cancer and to assess whether there were differences in stage at diagnosis, survival and eligibility for lung-cancer screening between the two groups. METHODS: Women who underwent lung-cancer resection between 2000 and 2017 were identified. Demographic, clinicopathological, treatment and outcomes data were compared between patients with a history of breast cancer (BC-Lung) and patients without a history of breast cancer (P-Lung) before lung cancer. RESULTS: Of 2192 patients included, 331 (15.1 per cent) were in the BC-Lung group. The most common method of lung-cancer diagnosis in the BC-Lung group was breast-cancer surveillance or work-up imaging. Patients in the BC-Lung group had an earlier stage of lung cancer at the time of diagnosis. Five-year overall survival was not statistically significantly different between groups (73.3 per cent for both). Overall, 58.4 per cent of patients (1281 patients) had a history of smoking, and 33.3 per cent (731 patients) met the current criteria for lung-cancer screening. CONCLUSION: Differences in stage at diagnosis of lung cancer and treatment selection were observed between patients with and without a history of breast cancer. Overall, there were no statistically significant differences in genomic or oncogenic pathway alterations between the two groups, which suggests that lung cancer in patients who previously had breast cancer may not be affected at the genomic level by the previous breast cancer. The most important finding of the study was that a high percentage of women with lung cancer, regardless of breast-cancer history, did not meet the current USPSTF criteria for lung-cancer screening. |
format | Online Article Text |
id | pubmed-8765335 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Oxford University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-87653352022-01-19 Primary lung cancer in women after previous breast cancer Nobel, Tamar B Carr, Rebecca A Caso, Raul Livschitz, Jennifer Nussenzweig, Samuel Hsu, Meier Tan, Kay See Sihag, Smita Adusumilli, Prasad S Bott, Matthew J Downey, Robert J Huang, James Isbell, James M Park, Bernard J Rocco, Gaetano Rusch, Valerie W Jones, David R Molena, Daniela BJS Open Original Article BACKGROUND: Breast cancer is the most common malignancy among women in the USA. Improved survival has resulted in increasing incidence of second primary malignancies, of which lung cancer is the most common. The United States Preventive Services Task Force (USPSTF) guidelines for lung-cancer screening do not include previous malignancy as a high-risk feature requiring evaluation. The aim of this study was to compare women undergoing resection for lung cancer with and without a history of breast cancer and to assess whether there were differences in stage at diagnosis, survival and eligibility for lung-cancer screening between the two groups. METHODS: Women who underwent lung-cancer resection between 2000 and 2017 were identified. Demographic, clinicopathological, treatment and outcomes data were compared between patients with a history of breast cancer (BC-Lung) and patients without a history of breast cancer (P-Lung) before lung cancer. RESULTS: Of 2192 patients included, 331 (15.1 per cent) were in the BC-Lung group. The most common method of lung-cancer diagnosis in the BC-Lung group was breast-cancer surveillance or work-up imaging. Patients in the BC-Lung group had an earlier stage of lung cancer at the time of diagnosis. Five-year overall survival was not statistically significantly different between groups (73.3 per cent for both). Overall, 58.4 per cent of patients (1281 patients) had a history of smoking, and 33.3 per cent (731 patients) met the current criteria for lung-cancer screening. CONCLUSION: Differences in stage at diagnosis of lung cancer and treatment selection were observed between patients with and without a history of breast cancer. Overall, there were no statistically significant differences in genomic or oncogenic pathway alterations between the two groups, which suggests that lung cancer in patients who previously had breast cancer may not be affected at the genomic level by the previous breast cancer. The most important finding of the study was that a high percentage of women with lung cancer, regardless of breast-cancer history, did not meet the current USPSTF criteria for lung-cancer screening. Oxford University Press 2022-01-18 /pmc/articles/PMC8765335/ /pubmed/35040941 http://dx.doi.org/10.1093/bjsopen/zrab115 Text en © The Author(s) 2022. Published by Oxford University Press on behalf of BJS Society Ltd. https://creativecommons.org/licenses/by-nc/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (https://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com |
spellingShingle | Original Article Nobel, Tamar B Carr, Rebecca A Caso, Raul Livschitz, Jennifer Nussenzweig, Samuel Hsu, Meier Tan, Kay See Sihag, Smita Adusumilli, Prasad S Bott, Matthew J Downey, Robert J Huang, James Isbell, James M Park, Bernard J Rocco, Gaetano Rusch, Valerie W Jones, David R Molena, Daniela Primary lung cancer in women after previous breast cancer |
title | Primary lung cancer in women after previous breast cancer |
title_full | Primary lung cancer in women after previous breast cancer |
title_fullStr | Primary lung cancer in women after previous breast cancer |
title_full_unstemmed | Primary lung cancer in women after previous breast cancer |
title_short | Primary lung cancer in women after previous breast cancer |
title_sort | primary lung cancer in women after previous breast cancer |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8765335/ https://www.ncbi.nlm.nih.gov/pubmed/35040941 http://dx.doi.org/10.1093/bjsopen/zrab115 |
work_keys_str_mv | AT nobeltamarb primarylungcancerinwomenafterpreviousbreastcancer AT carrrebeccaa primarylungcancerinwomenafterpreviousbreastcancer AT casoraul primarylungcancerinwomenafterpreviousbreastcancer AT livschitzjennifer primarylungcancerinwomenafterpreviousbreastcancer AT nussenzweigsamuel primarylungcancerinwomenafterpreviousbreastcancer AT hsumeier primarylungcancerinwomenafterpreviousbreastcancer AT tankaysee primarylungcancerinwomenafterpreviousbreastcancer AT sihagsmita primarylungcancerinwomenafterpreviousbreastcancer AT adusumilliprasads primarylungcancerinwomenafterpreviousbreastcancer AT bottmatthewj primarylungcancerinwomenafterpreviousbreastcancer AT downeyrobertj primarylungcancerinwomenafterpreviousbreastcancer AT huangjames primarylungcancerinwomenafterpreviousbreastcancer AT isbelljamesm primarylungcancerinwomenafterpreviousbreastcancer AT parkbernardj primarylungcancerinwomenafterpreviousbreastcancer AT roccogaetano primarylungcancerinwomenafterpreviousbreastcancer AT ruschvaleriew primarylungcancerinwomenafterpreviousbreastcancer AT jonesdavidr primarylungcancerinwomenafterpreviousbreastcancer AT molenadaniela primarylungcancerinwomenafterpreviousbreastcancer |